[Effect of polyvinypyrrolidone on the antineoplastic and toxic properties of some antiblastomatous preparations].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use / Q000633:toxicity; D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity*; D003520:Cyclophosphamide / Q000627:therapeutic use / Q000633:toxicity; D005419:Flavonoids / Q000627:therapeutic use / Q000633:toxicity; D005472:Fluorouracil / Q000627:therapeutic use / Q000633:toxicity; D007962:Leukocytes / Q000187:drug effects; D008970:Molecular Weight; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009848:Olivomycins / Q000627:therapeutic use / Q000633:toxicity; D010710:Phosphates; D011033:Podophyllin / Q000627:therapeutic use / Q000633:toxicity; D011205:Povidone / Q000627:therapeutic use*; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy; D013852:Thiotepa / Q000627:therapeutic use / Q000633:toxicity
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D005419:Flavonoids; D010710:Phosphates; D009848:Olivomycins; D003520:Cyclophosphamide; D011033:Podophyllin; D013852:Thiotepa; D011205:Povidone; D005472:Fluorouracil
Vliianie polivinilpirrolidona na protivoopukholevye i toksicheskie svoĭstva nekotorykh antiblastomykh preparatov.